Grey zones in cardiomyopathies: defining boundaries between genetic and iatrogenic disease

[1]  R. Farrington.  I'm Fine , 2018 .

[2]  C. Denson.  The MESA Study. , 2017 .

[3]  D. MacArthur,et al.  Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples , 2016, Genetics in Medicine.

[4]  S. Heymans,et al.  Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. , 2016, European heart journal.

[5]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.

[6]  B. Maron,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Circulation.

[7]  A. Barratt,et al.  Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection , 2015, Circulation. Cardiovascular genetics.

[8]  Mathew G. Wilson,et al.  See Clinical Perspective , 2022 .

[9]  A. Flett,et al.  Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy☆ , 2015, International journal of cardiology.

[10]  D. Adedinsewo,et al.  Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy. , 2015, The American journal of cardiology.

[11]  J. Paton,et al.  Insights from cardiovascular magnetic resonance imaging supporting the selfish brain hypothesis of arterial hypertension , 2015, Journal of Cardiovascular Magnetic Resonance.

[12]  E. Donal,et al.  Recognition and Significance of Pathological T-Wave Inversions in Athletes , 2015, Circulation.

[13]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.

[14]  D. Bluemke,et al.  The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study. , 2014, Journal of the American College of Cardiology.

[15]  E. Arbustini,et al.  Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? , 2014, Journal of the American College of Cardiology.

[16]  I. Heath.  Role of fear in overdiagnosis and overtreatment—an essay by Iona Heath , 2014, BMJ.

[17]  J. Bogaert,et al.  MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside. , 2014, Radiology.

[18]  K. Siminovitch,et al.  Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy. , 2014, European heart journal.

[19]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[20]  A. Tajik,et al.  Left ventricular noncompaction cardiomyopathy: lessons from the past to explain a diagnostic conundrum. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[21]  P. Elliott.  Myotonic dystrophy: time for evidence-based therapy. , 2014, European heart journal.

[22]  E. Cook,et al.  Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[23]  Barry J Maron,et al.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.

[24]  M. Haykowsky,et al.  LV hypertrophy in resistance or endurance trained athletes: the Morganroth hypothesis is obsolete, most of the time , 2014, Heart.

[25]  Mathew G. Wilson,et al.  Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and White Athletes , 2014, Circulation.

[26]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[27]  S. Colan,et al.  Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers Without Left Ventricular Hypertrophy , 2013, Circulation. Cardiovascular genetics.

[28]  F. T. ten Cate,et al.  Diastolic Abnormalities in Normal Phenotype Hypertrophic Cardiomyopathy Gene Carriers: A Study Using Speckle Tracking Echocardiography , 2013, Echocardiography.

[29]  D. Oxborough,et al.  Physiological Right Ventricular Adaptation in Elite Athletes of African and Afro-Caribbean Origin , 2013, Circulation.

[30]  A. Flett,et al.  Left ventricular non-noncompaction: the mitral valve prolapse of the 21st century? , 2013, International journal of cardiology.

[31]  Michael J Ackerman,et al.  Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy , 2013, British Journal of Sports Medicine.

[32]  Hein Heidbuchel,et al.  Normal electrocardiographic findings: recognising physiological adaptations in athletes , 2013, British Journal of Sports Medicine.

[33]  J. Rawlins.  Ethnic differences in cardiac adaptation to exercise , 2013 .

[34]  B. Carter.  2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology , 2013 .

[35]  David Gaze,et al.  The endurance athletes heart: acute stress and chronic adaptation , 2012, British Journal of Sports Medicine.

[36]  W. Manning,et al.  Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy , 2011, Circulation. Cardiovascular imaging.

[37]  M. Yacoub,et al.  Patterns of Disease Progression in Hypertrophic Cardiomyopathy: An Individualized Approach to Clinical Staging , 2012, Circulation. Heart failure.

[38]  Thomas J. Wang,et al.  Regression of "gray zone" exercise-induced concentric left ventricular hypertrophy during prescribed detraining. , 2012, Journal of the American College of Cardiology.

[39]  J. Seward,et al.  Left ventricular noncompaction: a 25-year odyssey. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  A. Tajik,et al.  Left ventricular noncompaction: a diagnostically challenging cardiomyopathy. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[41]  A. Tajik,et al.  Left ventricular noncompaction: a diagnostically challenging cardiomyopathy. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[42]  Kurt S. Hoffmayer,et al.  Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. , 2011, Journal of the American College of Cardiology.

[43]  R. Steiner,et al.  “I'm fine; I'm just waiting for my disease” , 2011, Neurology.

[44]  P. Elliott,et al.  Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.

[45]  G. Kervio,et al.  The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. , 2011, European heart journal.

[46]  P. Noseworthy,et al.  Significance of electrocardiographic right bundle branch block in trained athletes. , 2011, The American journal of cardiology.

[47]  W. Manning,et al.  Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy , 2010, Circulation.

[48]  P. Elliott,et al.  Impact of Genetics and Revised Task Force Criteria Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy , 2011 .

[49]  童鸿.  Recommendations for Interpretation of 12-lead Electrocardiogram in the Athlete , 2011 .

[50]  D. Corrado,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy. , 2010, Cardiac electrophysiology clinics.

[51]  A. Natale,et al.  Noninvasive Diagnosis of Electroanatomic Abnormalities in Arrhythmogenic Right Ventricular Cardiomyopathy , 2010, Circulation. Arrhythmia and electrophysiology.

[52]  H. Katus,et al.  Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy , 2010, Heart.

[53]  A. Keren,et al.  Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.

[54]  S. Colan,et al.  Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. , 2010, The New England journal of medicine.

[55]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[56]  P. Lambiase,et al.  Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. , 2009, European heart journal.

[57]  M. Yacoub,et al.  The Many Faces of Hypertrophic Cardiomyopathy: From Developmental Biology to Clinical Practice , 2009, Journal of cardiovascular translational research.

[58]  B. Maron,et al.  Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening , 2009, British Journal of Sports Medicine.

[59]  S. Firoozi,et al.  Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. , 2009, European heart journal.

[60]  Ana Morales,et al.  Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2009, Circulation. Heart failure.

[61]  A. Waldo.  Activation Delay and VT Parameters in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Toward Improvement of Diagnostic ECG Criteria , 2009 .

[62]  Luigi Rega,et al.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[63]  P. Rahko,et al.  Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. , 2008, American heart journal.

[64]  B. Maron,et al.  Relation of race to electrocardiographic patterns in elite American football players. , 2008, Journal of the American College of Cardiology.

[65]  B. Maron,et al.  Outcomes in athletes with marked ECG repolarization abnormalities. , 2008, The New England journal of medicine.

[66]  P. Elliott,et al.  Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? , 2007, European heart journal.

[67]  J. Stockman.  Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program , 2008 .

[68]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[69]  艶琳.  Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity , 2006 .

[70]  J. Baron,et al.  An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Preventio , 2006 .

[71]  E. Aliot,et al.  Electroanatomic mapping characteristics of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[72]  Stefan Neubauer,et al.  Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[73]  DomenicoCorrado,et al.  Three-Dimensional Electroanatomic Voltage Mapping Increases Accuracy of Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2005 .

[74]  H. Heidbuchel,et al.  Recommendations for competitive sports participation in athletes with cardiovascular disease , 2005 .

[75]  J. Ménard,et al.  Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. , 2004, Journal of the American College of Cardiology.

[76]  M. Henein,et al.  Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[77]  A. Hutter,et al.  Echocardiographic characteristics of professional football players. , 2003, Journal of the American College of Cardiology.

[78]  田口和裕,et al.  呼吸障害,急性心不全で発見された,孤立性左室心筋ち密化障害(Isolated Noncompaction of Left Ventricular Myocardium)の1女児例 , 2003 .

[79]  J. Bourke,et al.  Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. , 2003, European heart journal.

[80]  S. Solomon,et al.  Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.

[81]  B. Maron,et al.  Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning , 2002, Circulation.

[82]  P. Kaufmann,et al.  Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy , 2001, Heart.

[83]  F. Gaita,et al.  Long-term follow-up of right ventricular monomorphic extrasystoles. , 2001, Journal of the American College of Cardiology.

[84]  W. Mckenna,et al.  Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. , 2000, The American journal of cardiology.

[85]  W. Mckenna,et al.  Physiological profile and predictors of cycling performance in ultra-endurance triathletes. , 2000, The Journal of sports medicine and physical fitness.

[86]  D. Ducloux,et al.  Ocular Venous Occlusion and Hyperhomocysteinemia , 1999, Annals of Internal Medicine.

[87]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[88]  W. Stevenson,et al.  Entrainment mapping and radiofrequency catheter ablation of ventricular tachycardia in right ventricular dysplasia. , 1998, Journal of the American College of Cardiology.

[89]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[90]  B. Maron,et al.  Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. , 1996, JAMA.

[91]  M. Proschan,et al.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. , 1991, The New England journal of medicine.

[92]  J. Perloff,et al.  Isolated noncompaction of left ventricular myocardium. A study of eight cases. , 1990, Circulation.

[93]  J B Seward,et al.  Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. , 1987, Journal of the American College of Cardiology.

[94]  [The European Society of Human Genetics]. , 1967, Annales de Genetique.

[95]  S. Sherlock.  THE LIVER IN HEART FAILURE RELATION OF ANATOMICAL, FUNCTIONAL, AND CIRCULATORY CHANGES , 1951, British heart journal.